Evidence map›Paper›PMID 34158830›Full record

ArticleEcancermedicalscience2021

Psycho-oncology service provisions for hospitalised cancer patients before and during the COVID-19 pandemic in an oncology centre in eastern India.

Arnab Mukherjee, Meheli Chatterjee, Shreshta Chattopadhyay, Chitralekha Bhowmick, Archisman Basu, Surya Bhattacharjee, Soumita Ghose, Soumitra Shankar Datta

Abstract read
In one paragraph

Article in Ecancermedicalscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Arnab MukherjeeDepartment of Palliative Care & Psycho-oncology, Tata Medical Centre, New Town, Rajarhat, Kolkata, West Bengal 700160, India.
Meheli ChatterjeeDepartment of Medical Oncology, Tata Medical Centre, New Town, Rajarhat, Kolkata, West Bengal 700160, India.
Shreshta ChattopadhyayDepartment of Palliative Care & Psycho-oncology, Tata Medical Centre, New Town, Rajarhat, Kolkata, West Bengal 700160, India.
Chitralekha BhowmickDepartment of Palliative Care & Psycho-oncology, Tata Medical Centre, New Town, Rajarhat, Kolkata, West Bengal 700160, India.
Archisman BasuDepartment of Medical Oncology, Tata Medical Centre, New Town, Rajarhat, Kolkata, West Bengal 700160, India.
Surya BhattacharjeeDepartment of Quality Assurance, Tata Medical Centre, New Town, Rajarhat, Kolkata, West Bengal 700160, India.
Soumita GhoseDepartment of Medical Administration, Tata Medical Centre, New Town, Rajarhat, Kolkata, West Bengal 700160, India.
Soumitra Shankar DattaDepartment of Palliative Care & Psycho-oncology, Tata Medical Centre, New Town, Rajarhat, Kolkata, West Bengal 700160, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAddressing the mental health needs of cancer patients and their caregivers improves the quality of care the patient receives in any cancer care ecosystem. International practice currently encourages integrated care for physical and mental health in oncology. The coronavirus disease (COVID-19) pandemic has affected the delivery of healthcare services across the world. The current research paper is on the psycho-oncology service provision for hospitalised cancer patients before and during the COVID-19 pandemic.

methodsAll patients who were referred to psycho-oncology services during the study period of 1 month, in the two successive years of 2019 and 2020, were included in the study. Retrospective data were collected from the centralised electronic medical records for patients. Data included cancer diagnosis, reason for admission, admitting team and reason for a psychiatric referral. Other parameters that were measured were the timing of the psychiatric assessment, psychiatric diagnosis and psycho-oncology care provided, which included psychological interventions carried out and medications prescribed. The overall institutional data on cancer care provision are also presented in brief to provide context to the psycho-oncology services.

resultsIntegrated psycho-oncology services reviewed and managed patients round the year in the hospital where the study was conducted. During the 1-month study period, in 2019 and 2020, the total number of hospitalised cancer patients managed by the services was 74 and 52, respectively. During the study period of 2020, 292 patients with cancer who were being treated in the hospital had tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tested on reverse transcription-polymerase chain reaction (RT-PCR) and 50 members of healthcare staff also tested positive. The most common diagnosis of patients was found to be stress-related adjustment disorder [16/74 (21.6%) in 2019 and 16/52 (30.8%) in 2020]. The paper discusses the common stressors voiced by the patients and their caregivers during the COVID-19 pandemic. Several challenges of providing psychological services were overcome by the team and the paper touches upon the common strategies that were used during the pandemic. Most patients did not need medications, but a significant minority did benefit from treatment with psychotropic medications. Simple psychological interventions such as sleep hygiene, supportive therapy sessions and psycho-education benefited many patients and were feasible even during the pandemic.

conclusionThe provision of psycho-oncology services to cancer patients and their caregivers was important before and during the COVID-19 pandemic.Watch a video which illustrates the psycho-oncology service provisions in an oncology centre in Eastern India during the COVID-19 pandemic here: https://ecancer.org/en/video/9707-psycho-oncology-service-provisions-for-hospitalised-cancer-patients-before-and-during-the-covid19-pandemic.

Indexed as

cancerCOVID-19oncologypsychiatrypsychological supportpsycho-oncologySARS-CoV-2

Identifiers

PMID34158830
PMCPMC8183654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.